Endocrine Balance
Biotechs lead fight against cancer
Biotechs lead the fight against cancer with next-generation treatments and clinical trials.
By emily johnson · Sep 11, 2026
Tag: lungcancer
Recovery Modalities
Bayer Moves Hyrnuo Into Frontline Lung Cancer
Bayer secured FDA approval for Hyrnuo lung cancer treatment, marking a major shift in frontline HER2-mutant NSCLC care based on new clinical data.
By Samoyed · Sep 10, 2026
Nutrient Synergy
Ivonescimab Meets Overall Survival Goal in NSCLC
Ivonescimab surpasses Keytruda in overall survival for NSCLC first-line treatment, demonstrating potential breakthrough in lung cancer therapy.
By emily johnson · Sep 7, 2026